• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Credit Suisse Lux Biotechnology Equity Fund

+ Add to Watchlist

CLABIOT:LX

429.69 USD 13.53 3.25%

As of 00:59:30 ET on 12/18/2014.

Snapshot for Credit Suisse Lux Biotechnology Equity Fund (CLABIOT)

Year To Date: +35.49% 3-Month: +14.43% 3-Year: +46.06% 52-Week Range: 292.42 - 432.48
1-Month: +6.93% 1-Year: +40.09% 5-Year: +28.13% Beta vs NBI: 1.02

Mutual Fund Chart for CLABIOT

No chart data available.
  • CLABIOT:LX 429.69
  • 1M
  • 1Y
Interactive CLABIOT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CLABIOT

Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.

Inception Date: 11-06-2001 Telephone: -
Managers: IRENE BEATRICE PUETTNER
Web Site: www.credit-suisse.com

Fundamentals for CLABIOT

NAV (on 2014-12-18) 429.69
Assets (M) (on 2014-12-18) 232.76
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for CLABIOT

No dividends reported

Fees & Expenses for CLABIOT

Front Load 3.00
Back Load 0.00
Current Mgmt Fee 2.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CLABIOT

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 185,484 19,744,772 9.635%
Celgene Corp 175,276 16,612,659 8.107%
Amgen Inc 108,973 15,306,348 7.469%
Biogen Idec Inc 42,745 14,140,473 6.900%
Vertex Pharmaceuticals Inc 94,000 10,557,140 5.152%
Regeneron Pharmaceuticals Inc 27,000 9,734,040 4.750%
Alexion Pharmaceuticals Inc 57,752 9,576,437 4.673%
BioMarin Pharmaceutical Inc 120,444 8,691,239 4.241%
Medivation Inc 80,000 7,909,600 3.860%
Incyte Corp 145,000 7,112,250 3.471%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil